PE20010935A1 - Compuestos antitromboticos - Google Patents

Compuestos antitromboticos

Info

Publication number
PE20010935A1
PE20010935A1 PE2000001308A PE0013082000A PE20010935A1 PE 20010935 A1 PE20010935 A1 PE 20010935A1 PE 2000001308 A PE2000001308 A PE 2000001308A PE 0013082000 A PE0013082000 A PE 0013082000A PE 20010935 A1 PE20010935 A1 PE 20010935A1
Authority
PE
Peru
Prior art keywords
pentasacarido
spacer
refers
antithrombotic compounds
pentascarido
Prior art date
Application number
PE2000001308A
Other languages
English (en)
Spanish (es)
Inventor
Tamara Theodora Maria Geertsen
Boeckel Constant Adriaan Anton Van
Cornelia Maria Tromp
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PE20010935A1 publication Critical patent/PE20010935A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PE2000001308A 1999-12-07 2000-12-06 Compuestos antitromboticos PE20010935A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204172 1999-12-07

Publications (1)

Publication Number Publication Date
PE20010935A1 true PE20010935A1 (es) 2001-09-20

Family

ID=8240976

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001308A PE20010935A1 (es) 1999-12-07 2000-12-06 Compuestos antitromboticos

Country Status (23)

Country Link
US (1) US6875755B2 (https=)
EP (1) EP1237897B1 (https=)
JP (1) JP4820517B2 (https=)
KR (1) KR100776607B1 (https=)
CN (1) CN1195767C (https=)
AR (1) AR026726A1 (https=)
AU (1) AU781846B2 (https=)
BR (1) BR0016217A (https=)
CA (1) CA2393042C (https=)
CO (1) CO5251449A1 (https=)
CZ (1) CZ303385B6 (https=)
HK (1) HK1047593A1 (https=)
HU (1) HUP0203471A3 (https=)
IL (2) IL149628A0 (https=)
NO (1) NO323059B1 (https=)
NZ (1) NZ519100A (https=)
PE (1) PE20010935A1 (https=)
PL (1) PL202840B1 (https=)
RU (1) RU2266913C2 (https=)
SK (1) SK287682B6 (https=)
TW (1) TWI289566B (https=)
WO (1) WO2001042262A2 (https=)
ZA (1) ZA200203799B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1440077B1 (en) * 2001-09-07 2013-05-01 Alchemia Limited Synthetic heparin pentasaccharides
US7208498B2 (en) 2002-07-15 2007-04-24 Merck & Co., Inc. Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
ATE370141T1 (de) 2002-10-07 2007-09-15 Merck & Co Inc Antidiabetische heterocyclische beta- aminoverbindungen als inhibitoren von dipeptidylpeptidase
CA2504735C (en) * 2002-11-07 2009-06-23 Merck & Co., Inc. Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
EP1589969A4 (en) 2003-01-17 2008-08-13 Merck & Co Inc 3-AMINO-4-PHENYLBUTANEAN DERIVATEALS DIPEPTIDYLPEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
CA2513684A1 (en) 2003-01-31 2004-08-19 Merck & Co., Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
US7560455B2 (en) 2003-05-14 2009-07-14 Merck & Co., Inc. 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
CN1798556A (zh) 2003-06-06 2006-07-05 麦克公司 作为治疗或者预防糖尿病的二肽基肽酶抑制剂的稠合吲哚
CN1809544A (zh) 2003-06-17 2006-07-26 麦克公司 作为二肽基肽酶抑制剂用于治疗或预防糖尿病的环己基甘氨酸衍生物
US7259160B2 (en) 2003-07-31 2007-08-21 Merck & Co., Inc. Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
EP1574516A1 (en) 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotic compound
TW200621794A (en) * 2004-10-06 2006-07-01 Akzo Nobel Nv Pulmonary administration of an antithrombotic compound
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
MY145269A (en) * 2005-10-10 2012-01-13 Organon Nv Antithrombotic dual inhibitors comprising a biotin label
JP6109574B2 (ja) 2009-12-18 2017-04-05 カタラン、フランス、バインハイム、ソシエテ、アノニムＣａｔａｌｅｎｔ Ｆｒａｎｃｅ Ｂｅｉｎｈｅｉｍ Ｓａ 合成オリゴサッカリドを含有する医薬経口剤形

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4115468A1 (de) * 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
DE4206858A1 (de) * 1992-03-05 1993-09-09 Behringwerke Ag Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
FR2704226B1 (fr) * 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
NZ264340A (en) * 1993-09-01 1995-04-27 Akzo Nobel Nv Bisconjugate comprising two saccharides and a spacer, use in pharmaceutical compositions
IL126893A (en) * 1997-11-19 2003-05-29 Akzo Nobel Nv Sulfated pentasaccharide derivatives and pharmaceutical compositions containing them
WO1999065934A1 (en) * 1998-06-17 1999-12-23 Akzo Nobel N.V. Antithrombotic compounds

Also Published As

Publication number Publication date
US20030114361A1 (en) 2003-06-19
WO2001042262A2 (en) 2001-06-14
RU2266913C2 (ru) 2005-12-27
NO20022689D0 (no) 2002-06-06
CA2393042A1 (en) 2001-06-14
SK7942002A3 (en) 2002-09-10
IL149628A0 (en) 2002-11-10
AU2003801A (en) 2001-06-18
JP2003520208A (ja) 2003-07-02
KR100776607B1 (ko) 2007-11-16
US6875755B2 (en) 2005-04-05
SK287682B6 (sk) 2011-06-06
TWI289566B (en) 2007-11-11
HUP0203471A2 (hu) 2003-02-28
HUP0203471A3 (en) 2003-03-28
NZ519100A (en) 2004-09-24
EP1237897B1 (en) 2015-01-14
ZA200203799B (en) 2003-10-29
IL149628A (en) 2010-04-29
EP1237897A2 (en) 2002-09-11
JP4820517B2 (ja) 2011-11-24
CA2393042C (en) 2011-06-28
CO5251449A1 (es) 2003-02-28
CZ303385B6 (cs) 2012-08-29
PL202840B1 (pl) 2009-07-31
KR20020070988A (ko) 2002-09-11
NO323059B1 (no) 2006-12-27
NO20022689L (no) 2002-06-06
PL355484A1 (en) 2004-05-04
HK1047593A1 (zh) 2003-02-28
CN1407989A (zh) 2003-04-02
CZ20021958A3 (cs) 2002-08-14
WO2001042262A3 (en) 2001-12-13
CN1195767C (zh) 2005-04-06
AR026726A1 (es) 2003-02-26
AU781846B2 (en) 2005-06-16
BR0016217A (pt) 2002-09-10

Similar Documents

Publication Publication Date Title
PE20010935A1 (es) Compuestos antitromboticos
ES2191977T3 (es) Soluciones y dispersiones en estado solido de farmacos poco solubles en agua.
ES2017647B3 (es) Nuevos tioeteres fenolicos como inhibidores de 5-lipoxigenasa.
BRPI9912175A (pt) peptídios de antígeno cd4-cdr2, composição farmacêutica compreendendo os mesmos bem como uso da mesma
AR023920A1 (es) COMPUESTOS DE TRIAZOLO[4,5-D]PIRIMIDINA, COMPOSICION FARMACEUTICA, USO DE DICHOS COMPUESTOS PARA PREPARAR MEDICAMENTOS, Y PROCESO PARA LA PREPARACION DE DICHOS COMPUESTOS Y COMPUESTOS uTILES COMO INTERMEDIARIOS
BR0007781A (pt) Conjugado fisiologicamente ativo, composição, e, processo para a produção de um conjugado de peg-gcsf
GT199900022A (es) Compuestos para el tratamiento de la isquemia
BR9914167A (pt) Composto, método de tratamento, inibição do crescimento de, ou erradicação de neoplasmas, e de doença de rim policìstico, em um mamìfero em necessidade do mesmo, composição farmacêutica, e processo para preparar o composto
BR9811948A (pt) Secretores de hormÈnio do crescimento
AR039672A1 (es) Dipeptido, derivado de benzotiazepina. inhibidor del transporte ileal de acidos biliares (ibat)
ES2032613T3 (es) Procedimiento para la preparacion de derivados de la didehidro-vitamina d3. (reserva del art. 167.2 cpe).
ES2100943T3 (es) Derivado de bencenosulfonamida.
ES2055159T3 (es) Composiciones que inducen la union entre partes de tejido mineralizado vivo.
ES525692A0 (es) Procedimiento para la obtencion de dihidropirimidinas
PE20010962A1 (es) Derivados de heterociclo-alquilsulfonil-pirazol como agentes anti-inflamatorios/analgesicos
GT199900154A (es) Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
AR026063A1 (es) Metodo para la preparacion de 5-carboxiftalida.
EA200000896A1 (ru) S-ЗАМЕЩЕННЫЕ ТИОЛОВЫЕ ЭФИРЫ 11b-БЕНЗАЛЬДОКСИМЭСТРА-4,9-ДИЕНУГОЛЬНОЙ КИСЛОТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
ES545330A0 (es) Un procedimiento para preparar derivados de 1,3-difosfonato
DE60016181D1 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
AR009429A1 (es) Compuestos fenoles y tiofenoles sustituidos utiles como agentes antioxidantes y usos para la fabricacion de medicamentos
CO5160271A1 (es) Composicion de alta pureza que comprende (7 alfa, 17 alfa)- 17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona
ES2107806T3 (es) Nuevos esteroides.
BR0010381A (pt) Método de tratamento da trombose em um mamìfero, e uso de uma combinação de (i) um inibidor do fator xa, e (ii) um composto selecionado do grupo que consiste em aspirina, tpa, um antagonista gpiib/iiia, heparina de baixo peso molecular e heparina
ES2159054T3 (es) Compuestos di-terc-butil-fenolicos que contienen azufre utiles como agentes antiinflamatorios.

Legal Events

Date Code Title Description
FG Grant, registration
AE Restoration of lapsed or forfeited application
FG Grant, registration
FD Application declared void or lapsed